The research study evaluating Bucillamine remains in progress, and the Company is awaiting the final findings, which will be released only with the express authorization of DRDC. Revive will continue ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Researchers discovered that chemotherapy can accidentally trigger a stress alarm in immune cells, causing inflammation that ...

Chemotherapy appears to activate a stress-sensing system inside immune cells. According to new research from Weill Cornell Medicine and Wake Forest ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients ...

Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell ...

Contineum's Multiple Sclerosis drug missed key goals in a Phase 2 trial as RBC cut its target but highlighted stronger ...

Tulane researchers discovered a new pain signaling mechanism that could lead to safer, more effective treatments and reshape ...

Pulsetto earned the 2025 Global Recognition Award for adapting medical-grade bilateral vagus nerve stimulation into a ...

The Pasadena Public Health Department (PPHD) is urging parents and caregivers to immediately discontinue use of ByHeart Whole ...

These four practices, collected with the help of Sustainable Southeast Partnership partners, are ‘recipes’ rooted in ...